ArticleCancer immunology, immunotherapy : CII2026
Broader gene representation by whole-exome sequencing improves accuracy of tumor mutational burden assessment for selection of pembrolizumab immunotherapy.
Milan Radovich et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.